Status: current, Defined. Date: 29-Feb 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1534691000168113 | ascorbic acid 250 mg + cupric oxide 1.25 mg + d-alpha-tocopheryl acid succinate 165 mg + zinc oxide 49.8 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1534701000168113 | ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Is a | ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper | true | Inferred relationship | Some | ||
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has unit of use | tablet | true | Inferred relationship | Some | 2054743569 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has intended active ingredient | d-alpha-tocopheryl acid succinate | true | Inferred relationship | Some | 530033956 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has Australian BoSS | d-alpha-tocopheryl acid succinate | true | Inferred relationship | Some | 530033956 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has Australian BoSS | zinc oxide | true | Inferred relationship | Some | 2054743568 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has intended active ingredient | zinc | true | Inferred relationship | Some | 2054743568 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has Australian BoSS | cupric oxide | true | Inferred relationship | Some | 167072881 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has intended active ingredient | copper | true | Inferred relationship | Some | 167072881 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has Australian BoSS | ascorbic acid | true | Inferred relationship | Some | 1971158572 | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | has intended active ingredient | ascorbic acid | true | Inferred relationship | Some | 1971158572 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Macu-Vision tablet | Is a | True | ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Inferred relationship | Some | |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet, 30 | has MPUU | True | ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Inferred relationship | Some | 1 |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet, 150 | has MPUU | True | ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Inferred relationship | Some | 1 |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet, 90 | has MPUU | True | ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet | Inferred relationship | Some | 1 |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR